The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for ...

BioPharm International® sat down with Noah Kopcho, field application scientist at Gyros Protein Technologies, to talk about ...

The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about how technological advances will impact the biopharma industry in the future.

As therapeutic modalities evolve, so do the challenges and methodologies associated with maintaining and verifying cleanroom ...

The pandemic made it daunting for companies to retain talent and then find it anew, but just as that cloud is lifting and ...

The pharma industry is focused on strengthening its foundation, embracing innovation, and future-proofing its path forward.

The company is presenting data related to its medications designed to advance the prevention and treatment of asthma and COPD.

While global harmonization exists, there are still differences between the US and European GMP requirements that ...

Donald Ingber, MD, PhD; Miguel Forte, MD, PhD; Ali Pashazadeh, MRCS, MBA; and Adam Inche, PhD, MBA go behind the headlines to ...

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance ...

How BioDuro is expanding its global CRDMO footprint by improving integrated capabilities and delivering high-quality, ...